ALLO Sale Disclosure
Parker Geoffrey M. · SEC Form 4 · Filed Oct 23, 2026
Sale
Calculated transaction value
$48.7K
Parker Geoffrey M. Chief Financial Officer
ALLO
Transaction date
Oct 21, 2026
Public filing date
Oct 23, 2026
Filing lag
Filed 2 days later
ALLO daily price context
Close on/before transaction
$1.33
Oct 21, 2026
First close after public filing
$1.21
Oct 26, 2026
Return after filing · so far
-12.4%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 36,342 shares @ $1.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001491874-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$48.7K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Allogene Therapeutics, Inc. ALLO Current | Sale | Oct 21, 2026 | $48.7K |